Form 8-K - Current report:
SEC Accession No. 0001493152-25-002751
Filing Date
2025-01-17
Accepted
2025-01-17 16:05:18
Documents
15
Period of Report
2025-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49448
2 ex10-1.htm EX-10.1 131948
3 ex10-2.htm EX-10.2 23157
  Complete submission text file 0001493152-25-002751.txt   416758

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ogen-20250115.xsd EX-101.SCH 3018
5 XBRL LABEL FILE ogen-20250115_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ogen-20250115_pre.xml EX-101.PRE 24167
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3651
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 25538679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)